Beyza Ayazgök

557 citations

19 papers · 383 indexed · h-index 13

Pharmacology top 5%
Computational Theory and Mathematics top 5%
Organic Chemistry top 10%
Physiology
Molecular Biology

Co-authors: Tuba Tüylü Küçükkılınç Alireza Foroumadi Hamid Nadri Mehdi Khoobi Ayla Balkan Keriman Ozadali‐Sari Oya Ünsal Tan Hamid Forootanfar
Topics: Cholinesterase and Neurodegenerative Diseases (14 papers)Computational Drug Discovery Methods (12 papers)Alzheimer's disease research and treatments (6 papers)
Cited by: Pharmacology Computational Theory and Mathematics Biological Psychiatry
Journals: European Journal of Medicinal Chemistry Progress in Neuro-Psychopharmacology and Biological Psychiatry Journal of Molecular Structure
Partner nations: Türkiye Iran Cyprus

In The Last Decade

Beyza Ayazgök

19 papers receiving 376 citations

Peers

Countries citing papers authored by Beyza Ayazgök

Since Specialization

Citations

This map shows the geographic impact of Beyza Ayazgök's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beyza Ayazgök with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beyza Ayazgök more than expected).

Fields of papers citing papers by Beyza Ayazgök

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beyza Ayazgök. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beyza Ayazgök. The network helps show where Beyza Ayazgök may publish in the future.

Co-authorship network of co-authors of Beyza Ayazgök

This figure shows the co-authorship network connecting the top 25 collaborators of Beyza Ayazgök. A scholar is included among the top collaborators of Beyza Ayazgök based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beyza Ayazgök. Beyza Ayazgök is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Synthesis of New 3-Arylcoumarins Bearing N-Benzyl Triazole Moiety: Dual Lipoxygenase and Butyrylcholinesterase Inhibitors With Anti-Amyloid Aggregation and Neuroprotective Properties Against Alzheimer’s Disease 2022 ·Frontiers in Chemistry ·(unknown),Tuba Tüylü Küçükkılınç,(unknown),Beyza Ayazgök,Hamid Nadri,(unknown),Hamid Forootanfar,Tayebeh Akbari,Mohammad Shafiei,Alireza Foroumadi,Mohammad Sharifzadeh,Mehdi Shafiee Ardestani,M. Saeed Abaee,Loghman Firoozpour,Mehdi Khoobi,Mohammad M. Mojtahedi	13
2	Chromone–lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities 2021 ·DARU Journal of Pharmaceutical Sciences ·Leili Jalili‐Baleh,Hamid Nadri,Hamid Forootanfar,Tuba Tüylü Küçükkılınç,Beyza Ayazgök,Mohammad Sharifzadeh,Mahban Rahimifard,Maryam Baeeri,Mohammad Abdollahı,Alireza Foroumadi,Mehdi Khoobi	23
3	Hybridization‐based design of novel anticholinesterase indanone–carbamates for Alzheimer's disease: Synthesis, biological evaluation, and docking studies 2021 ·Archiv der Pharmazie ·(unknown),Maryam Hamzeh‐Mivehroud,Salar Hemmati,Javid Shahbazi Mojarrad,Tuba Tüylü Küçükkılınç,Beyza Ayazgök,Siavoush Dastmalchi	11
4	Ketamine induces rapid and sustained antidepressant-like effects in chronic pain induced depression: Role of MAPK signaling pathway 2020 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·(unknown),Beyza Ayazgök,Léa J. Becker,Elisabeth Waltisperger,Tomi Rantamäki,İpek Yalçın	42
5	Design, synthesis, and biological evaluation of novel indanone-based hybrids as multifunctional cholinesterase inhibitors for Alzheimer's disease 2020 ·Journal of Molecular Structure ·(unknown),Maryam Hamzeh‐Mivehroud,Salar Hemmati,Javid Shahbazi Mojarrad,Behrouz Notash,Tuba Tüylü Küçükkılınç,Beyza Ayazgök,Siavoush Dastmalchi	18
6	Synthesis, molecular docking, and biological evaluation of novel 2-pyrazoline derivatives as multifunctional agents for the treatment of Alzheimer's disease 2019 ·MedChemComm ·Oya Ünsal Tan,Tuba Tüylü Küçükkılınç,Beyza Ayazgök,Ayla Balkan,Keriman Ozadali‐Sari	15
7	New classes of carbazoles as potential multi-functional anti-Alzheimer’s agents 2019 ·Bioorganic Chemistry ·(unknown),(unknown),Leili Jalili‐Baleh,Hamid Nadri,Tuba Tüylü Küçükkılınç,Beyza Ayazgök,Alireza Moradi,Farshad Homayouni Moghadam,(unknown),Alieh Ameri,Fatemeh Salehian,Alireza Foroumadi,Mehdi Khoobi	21
8	Neurotoxic effects of bisphenol A on SH-SY5Y neuroblastoma cells via nitric oxide 2019 ·Journal of Research in Pharmacy ·Beyza Ayazgök,Tuba Tüylü Küçükkılınç	5
9	3‐Aryl Coumarin Derivatives Bearing Aminoalkoxy Moiety as Multi‐Target‐Directed Ligands against Alzheimer's Disease 2019 ·Chemistry & Biodiversity ·(unknown),(unknown),Hamid Nadri,(unknown),(unknown),Hamid Forootanfar,Alieh Ameri,Tuba Tüylü Küçükkılınç,Beyza Ayazgök,Leili Jalili‐Baleh,Seyed Esmaeil Sadat Ebrahimi,Setareh Moghimi,Ismaeil Haririan,Mehdi Khoobi,Alireza Foroumadi	12
10	Discovery of Novel 1,2,4-triazolo-1,2,4-triazines with Thiomethylpyridine Hinge Binders as Potent c-Met Kinase Inhibitors 2019 ·Future Medicinal Chemistry ·Sakineh Dadashpour,Tuba Tüylü Küçükkılınç,Beyza Ayazgök,Seyed Jalal Hosseinimehr,Ann M. Chippindale,Alireza Foroumadi,Hamid Irannejad	11
11	Design and Synthesis of 2-Substitutedphenyl Benzo[D]Thiazole Derivatives and Their β-Amyloid Aggregation and Cholinesterase Inhibitory Activities 2019 ·Pharmaceutical Chemistry Journal ·(unknown),Oya Ünsal Tan,Tuba Tüylü Küçükkılınç,Beyza Ayazgök,Ayla Balkan	4
12	Synthesis and Biological Assessment of 2-Hydroxyiminoethanones as Anti-Inflammatory and β-Amyloid Aggregation Inhibitors. 2019 ·PubMed ·Mehdi Valipour,(unknown),(unknown),(unknown),Tuba Tüylü Küçükkılınç,Beyza Ayazgök,Hamid Irannejad	2
13	Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds 2018 ·European Journal of Medicinal Chemistry ·Leili Jalili‐Baleh,Hamid Forootanfar,Tuba Tüylü Küçükkılınç,Hamid Nadri,(unknown),Alieh Ameri,Mandana Jafari,Beyza Ayazgök,Maryam Baeeri,Mahban Rahimifard,Syed Nasir Abbas Bukhari,Mohammad Abdollahı,Mohammad Reza Ganjali,Saeed Emami,Mehdi Khoobi,Alireza Foroumadi	63
14	Novel 3-phenylcoumarin–lipoic acid conjugates as multi-functional agents for potential treatment of Alzheimer's disease 2018 ·Bioorganic Chemistry ·Leili Jalili‐Baleh,Hamid Nadri,Hamid Forootanfar,Alireza Samzadeh‐Kermani,Tuba Tüylü Küçükkılınç,Beyza Ayazgök,Mahban Rahimifard,Maryam Baeeri,Mohsen Doostmohammadi,Loghman Firoozpour,Syed Nasir Abbas Bukhari,Mohammad Abdollahı,Mohammad Reza Ganjali,Saeed Emami,Mehdi Khoobi,Alireza Foroumadi	41
15	Low‐dose bisphenol A induces RIPK1‐mediated necroptosis in SH‐SY5Y cells: Effects on TNF‐α and acetylcholinesterase 2018 ·Journal of Biochemical and Molecular Toxicology ·Beyza Ayazgök,Tuba Tüylü Küçükkılınç	13
16	Synthesis and biological evaluation of new N-benzylpyridinium-based benzoheterocycles as potential anti-Alzheimer’s agents 2018 ·Bioorganic Chemistry ·(unknown),Bi Bi Fatemeh Mirjalili,Hamid Nadri,(unknown),Hamid Forootanfar,Alireza Samzadeh‐Kermani,Tuba Tüylü Küçükkılınç,Beyza Ayazgök,Saeed Emami,Ismaeil Haririan,Mohammad Sharifzadeh,Alireza Foroumadi,Mehdi Khoobi	28
17	Novel multi-targeted agents for Alzheimer's disease: Synthesis, biological evaluation, and molecular modeling of novel 2-[4-(4-substitutedpiperazin-1-yl)phenyl]benzimidazoles 2017 ·Bioorganic Chemistry ·Keriman Ozadali‐Sari,Tuba Tüylü Küçükkılınç,Beyza Ayazgök,Ayla Balkan,Oya Ünsal Tan	37
18	Synthesis and neuroprotective activity of novel 1,2,4-triazine derivatives with ethyl acetate moiety against H 2 O2 and Aβ-induced neurotoxicity 2017 ·Medicinal Chemistry Research ·Tuba Tüylü Küçükkılınç,(unknown),Beyza Ayazgök,(unknown),Farshad Homayouni Moghadam,Alireza Moradi,Saeed Emami,Mohsen Amini,Hamid Irannejad	13
19	Novel 2-Arylbenzimidazole derivatives as multi-targeting agents to treat Alzheimer’s disease 2017 ·Medicinal Chemistry Research ·Oya Ünsal Tan,Keriman Ozadali‐Sari,Beyza Ayazgök,Tuba Tüylü Küçükkılınç,Ayla Balkan	11

About Beyza Ayazgök

Beyza Ayazgök is a scholar working on Pharmacology, Computational Theory and Mathematics and Biochemistry, having authored 19 papers that have together received 383 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (14 papers), Computational Drug Discovery Methods (12 papers) and Alzheimer's disease research and treatments (6 papers). The work is most often cited by research in Pharmacology (233 citations), Computational Theory and Mathematics (177 citations) and Biological Psychiatry (19 citations). Beyza Ayazgök has collaborated with scholars based in Türkiye, Iran and Cyprus. Frequent co-authors include Tuba Tüylü Küçükkılınç, Alireza Foroumadi, Hamid Nadri, Mehdi Khoobi, Ayla Balkan, Keriman Ozadali‐Sari, Oya Ünsal Tan, Hamid Forootanfar, Leili Jalili‐Baleh and Saeed Emami. Their work appears in journals such as European Journal of Medicinal Chemistry, Progress in Neuro-Psychopharmacology and Biological Psychiatry and Journal of Molecular Structure.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact